Radiation showdown: which schedule beats childhood brain cancer?
NCT ID NCT01351870
First seen Sep 30, 2025 · Last updated May 14, 2026 · Updated 33 times
Summary
This study tested two different ways of giving radiation to children and teens (ages 4 to 21) with a standard-risk brain tumor called medulloblastoma. One method used smaller, more frequent doses (hyperfractionated), while the other used standard daily doses. The goal was to see which approach better prevents the tumor from coming back and helps patients live longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDULLOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.